Proteon Therapeutics
Get Full AccessDescription
- Proteon Therapeutics is committed to improving the health of patients with kidney and vascular diseases through the development of novel, first-in-class therapeutics. Proteons lead product candidate, vonapanitase (formerly PRT-201), is an investigational drug designed to treat vessel injury response that leads to blockages in blood vessels and reduced blood flow. Proteon is currently evaluating investigational vonapanitase in PATENCY-1 and PATENCY-2, two Phase 3 clinical trials in patients with chronic kidney disease (CKD) undergoing surgical creation of a radiocephalic arteriovenous fistula (RC AVF) for hemodialysis. Proteon has also completed a Phase 1 clinical trial in patients with symptomatic peripheral artery disease (PAD).
-
Headquarters:200 West St Ste 1, Waltham, Massachusetts, United States
More -
Phone Number: +1 781-890-0102
-
Website: https://www.proteontherapeutics.com
-
Employees:20
-
Revenue:$10 - 50M
-
Legal Name:Proteon Therapeutics
-
Proteon Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 621111 |
Show More
Frequently Asked Questions regarding Proteon Therapeutics
-
Where are Proteon Therapeutics's Headquarters?
Proteon Therapeutics's Headquarters are in 200 West St Ste 1,Waltham,Massachusetts,United States
-
What is Proteon Therapeutics's phone number?
Proteon Therapeutics's phone number is +1 781-890-0102
-
What is Proteon Therapeutics's official website?
Proteon Therapeutics's official website is https://www.proteontherapeutics.com
-
What is Proteon Therapeutics's Revenue?
Proteon Therapeutics's revenue is $10 - 50M
-
What is Proteon Therapeutics's NAICS code?
Proteon Therapeutics's NAICS code is 621111
-
How many employees are working in Proteon Therapeutics
Proteon Therapeutics has 20 employees
-
What is Proteon Therapeutics's Industry?
Proteon Therapeutics is in the industry of Biotechnology
-
Who is Proteon Therapeutics's Vice President Operations?
Proteon Therapeutics's Vice President Operations is Robert Martin

